Nathan Vardi


Nathan Vardi is the managing editor, enterprise, at MarketWatch, where he oversees long-form, feature and investigative reporting efforts. He is also the author of “For Blood & Money,” a book about the development of rival oncology drugs to be published by W.W. Norton & Co. Previously, Nathan was a senior editor at Forbes, where he was responsible for the coverage of Wall Street and big investors, including hedge funds and private equity. He led investigative reporting efforts and also focused on the intersection of big money and biopharma.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved